Board Approved the appointment of Babita as an Non Executive & Independent Director w.e.f. 31st January 2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Johnson Pharmacare Ltd informed BSE that its Board of Directors, at a meeting held on 31st January 2026, approved the appointment of Ms. Babita (DIN: 09064124) as a Non-Executive & Independent Director with effect from 31st January 2026. As per the brief profile, Ms. Babita is a graduate, born on 04/12/1991, with no disclosed inter-se relationship with other directors. The company also submitted a declaration confirming she has not been debarred by SEBI or any other authority from holding the office of director. The intimation was signed by Rajender Parsad, Additional Director.
This is a routine regulatory compliance filing regarding the induction of an independent director. It is unlikely to have any material impact on the stock price or shareholder value, though it indicates the company is meeting board composition norms under SEBI listing regulations.